Breaking News
About Philipp Mathieu
Mr. Mathieu is an experienced leader with a solid background in strategic development of international companies and all issues related to capital and investment. He has recently served in a combined position as a Portfolio Manager and Investment Advisor in an international company, based in Switzerland and Sweden. Before this experience he gained insight and experience in several positions at the Healthcare group Lazard. Focusing on the development and future of the company, Mr. Mathieu gave strategic advice in capital markets transactions for clients across Europe and the US.
Related Story
Immunovia Appoints Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs
January 17 2023
Immunovia, the diagnostics company that has launched the world’s first blood test dedicated to the […]
The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase
June 30 2022
Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]
Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business
March 28 2022
Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He […]